Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
  1. 4 Grant or award Director acquired 7,609 shares (grant or award)
  2. 4 Grant or award Director acquired 7,609 shares (grant or award)
  3. 4 Grant or award Director acquired 7,609 shares (grant or award)
  4. 4 Gift Watanabe Todd Franklin gave 1,994 shares (gift)
  5. 4 Open-market buy Director bought 2,268 shares at an average $13.34 ($30,247)
  6. 4 Planned sale Matsuda Masaru sold 1,800 shares at $13.78 ($24,807)
  7. 4 Open-market buy Director bought 5,040 shares at an average $13.66 ($68,821)
  8. 4 Planned sale Edwards Larry Todd sold 7,451 shares at $14.07 ($104,850)
  9. 4 Open-market buy Director bought 2,520 shares at $13.62 ($34,317)
  10. 4 Open-market buy Director bought 8,674 shares at an average $13.76 ($119,352)
  11. 4 Open-market buy Director bought 6,300 shares at $13.60 ($85,691)
  12. 4 Planned sale Burnett Patrick sold 3,871 shares at $13.59 ($52,623)
  13. 4 Grant or award SVP Chief Financial Officer acquired 20,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Planned sale Matsuda Masaru sold 5,030 shares at $15.20 ($76,453)
  16. 4 Planned sale Watanabe Todd Franklin sold 11,448 shares at $15.19 ($173,917)
  17. 4 Planned sale Burnett Patrick sold 2,597 shares at $15.19 ($39,442)
  18. 4 Planned sale Director sold 10,000 shares at $14.64 ($146,357)
  19. 4 Planned sale Director sold 10,000 shares at $15.12 ($151,236)
  20. 4 Planned sale Chief Financial Officer sold 9,600 shares at $15.80 ($151,698)

Page 6 of 23 · 452 filings